Selenium in cancer prevention: A review of the evidence and mechanism of action

Proceedings of the Nutrition Society

Volumn 64, Issue 4, 2005, Pages 527-542

  Rayman, Margaret P ^a  

^a UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

Cancer; Mechanism; Selenium; Selenomethyl selenocysteine; Selenoprotein single nucleotide polymorphism

Indexed keywords

ALPHA TOCOPHEROL; ANTINEOPLASTIC AGENT; DRUG METABOLITE; GAMMA GLUTAMYLSELENOMETHYLSELENOCYSTEINE; GLUTATHIONE PEROXIDASE; METHYL SELENOL; SELENIUM; SELENOCYSTEINE; SELENOMETHIONINE; SELENOMETHYLSELENOCYSTEINE; SELENOPROTEIN; SELENOPROTEIN P; UNCLASSIFIED DRUG;

APOPTOSIS; BIOSYNTHESIS; CANCER GROWTH; CANCER MORTALITY; CANCER PREVENTION; CANCER RISK; CANCER STAGING; CAUCASIAN; CELL CYCLE; CHINESE; CLINICAL TRIAL; COLORECTAL ADENOMA; CONFERENCE PAPER; CONFIDENCE INTERVAL; DIET SUPPLEMENTATION; DIETARY INTAKE; DNA DAMAGE; DNA POLYMORPHISM; DRUG EFFICACY; ESOPHAGUS CANCER; GENOTYPE; HUMAN; LUNG CANCER; META ANALYSIS; METASTASIS; NONHUMAN; OXIDATIVE STRESS; PROSTATE CANCER; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH CANCER; SYSTEMATIC REVIEW;

ANTICARCINOGENIC AGENTS; ANTINEOPLASTIC AGENTS; APOPTOSIS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOTYPE; HUMANS; NEOPLASMS; OXIDATION-REDUCTION; SELENIUM; SELENOCYSTEINE; SELENOPROTEINS;

ANIMALIA;

EID: 28244462778     PISSN: 00296651     EISSN: None     Source Type: Journal    
DOI: 10.1079/PNS2005467     Document Type: Conference Paper

References (124)

1. Akbaraly NT, Arnaud J, Hininger-Favier I, Gourlet V, Roussel A-M & Berr C (2005) Selenium and mortality in the elderly: results from the EVA study. Clinical Chemistry (In the Press).
2. Alberts DS, Martinez ME, Roe DJ, Guillen-Rodriguez JM, Marshall JR, van Leeuwen JB et al. (2000) Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. Phoenix Colon Cancer Prevention Physicians' Network. New England Journal of Medicine 342, 1156-1162.
3. Allan CB, Lacourciere GM & Stadtman TC (1999) Responsiveness of selenoproteins to dietary selenium. Annual Review of Nutrition 19, 1-16.
4. Apostolou S, Klein JO, Mitsuuchi Y, Shetler JN, Poulikakos PI, Jhanwar SC, Kruger WD & Testa JR (2004) Growth inhibition and induction of apoptosis in mesothelioma cells by selenium and dependence on selenoprotein SEP15 genotype. Oncogene 23, 5032-5040.
5. Arteel GE, Briviba K & Sies H (1999) Protection against peroxynitrite. FEBS Letters 445, 226-230.
6. Behne D, Kyriakopoulos A, Kalcklosch M, Weiss-Nowak C, Pfeifer H, Gessner H & Hammel C (1997) Two new selenoproteins found in the prostatic glandular epithelium and in the spermatid nuclei. Biomedical and Environmental Science 10, 340-345.
7. Berry MJ, Banu L, Chen YY, Mandel SJ, Kieffer JD, Harney JW & Larsen PR (1991) Recognition of UGA as a selenocysteine codon in type I deiodinase requires sequences in the 3′ untranslated region. Nature 353, 273-276.
8. Berry MJ, Banu L, Harney JW & Larsen PR (1993) Functional characterization of the eukaryotic SECIS elements which direct selenocysteine insertion at UGA codons. The EMBO Journal 12, 3315-3322.
9. Bjelakovic G, Nikolova D, Simonetti RG & Gluud C (2004) Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and meta-analysis. Lancet 364, 1219-1228.
10. Blot WJ, Li JY, Taylor PR Guo W, Dawsey S, Wang GQ, Yang CS, Zheng SF, Gail M, Li GY et al. (1993) Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. Journal of the National Cancer Institute 85, 1483-1492.
11. Broadley MR, Meacham MC, Bowen HC, Johnson SE, White PJ, Breward N, Johnson CC, Bryson RJ, Harriman M & Tucker M (2006) Agronomic approaches for the enrichment of food crops with selenium. Proceedings of the Nutrition Society (In the Press).
12. Brooks JD, Metter EJ, Chan DW, Sokoll LJ, Landis P, Nelson WG, Muller D, Andres R & Carter HB (2001) Plasma selenium level before diagnosis and the risk of prostate cancer development. Journal of Urology 166, 2034-2038.
13. Brown KM & Arthur JR (2001) Selenium, selenoproteins and human health: a review. Public Health Nutrition 4, 593-599.
14. Brown KM, Pickard K, Nicol F, Beckett GJ, Duthie GG & Arthur JR (2000) Effects of organic and inorganic selenium supplementation on selenoenzyme activity in blood lymphocytes, granulocytes, platelets and erythrocytes. Clinical Science (London) 98, 593-599.
15. Burk RF, Hill KE & Motley AK (2003) Selenoprotein metabolism and function: evidence for more than one function for selenoprotein P. Journal of Nutrition 133, Suppl. 1, 1517S-1520S.
16. CancerStats (2004a) Mortality UK. http://info.cancerresearchuk. org/cancerstats/mortality/(accessed February 2004)
17. CancerStats (2004b) Cancer in the EU. http://info.cancerresearch uk.org/cancerstats/geographic/cancerineu/ (accessed November 2004)
18. Calvo A, Xiao N, Kang J, Best CJ, Leiva I, Emmert-Buck MR, Jorcyk C & Green JE (2002) Alterations in gene expression profiles during prostate cancer progression: functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors. Cancer Research 62, 5325-5335.
19. Caruso C, Lio D, Cavallone L & Franceschi C (2004) Aging, longevity, inflammation, and cancer. Annals of the New York Academy of Sciences 1028, 1-13.
20. Clark LC, Cantor KP & Allaway WH (1991) Selenium in forage crops and cancer mortality in U.S. counties. Archives of Environmental Health 46, 37-42.
21. Clark LC, Combs GF Jr, Turnbull BW, Slate EH, Chalker DK, Chow J et al. (1996) Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. Journal of the American Medical Association 276, 1957-1963.
22. Clark LC, Dalkin B, Krongrad A, Combs GF Jr, Turnbull BW, Slate EH et al. (1998) Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial. British Journal of Urology 81, 730-734.
23. Combs GF Jr (2001) Selenium in global food systems. British Journal of Nutrition 85, 517-547.
24. Combs GF Jr (2005) Current evidence and research needs to support a health claim for selenium and cancer prevention. Journal of Nutrition 135, 343-347.
25. Combs GF Jr & Gray WP (1998) Chemopreventive agents: selenium. Pharmacological Therapy 79, 179-192.
26. Combs GF Jr & Lü J (2001) Selenium as a cancer preventive agent. In Selenium: Its Molecular Biology and Role in Human Health, pp. 205-218 [DL Hatfield, editor]. Dordrecht, The Netherlands: Kluwer Academic Publishers.
27. Davis CD & Finley JW (2003) Chemical versus food forms of selenium in cancer prevention. In Functional Foods and Nutraceuticals in Cancer Prevention, pp. 55-85 [RR Watson, editor]. Ames, IA: Iowa State Press.
28. Davis CD & Uthus EO (2003) Dietary folate and selenium affect dimethylhydrazine-induced aberrant crypt formation, global DNA methylation and one-carbon metabolism in rats. Journal of Nutrition 133, 2907-2914.
29. Davis CD, Uthus EO & Finley JW (2000) Dietary selenium and arsenic affect DNA methylation in vitro in Caco-2 cells and in vivo in rat liver and colon. Journal of Nutrition 130, 2903-2909.
30. Diplock AT (1993) Indexes of selenium status in human populations. American Journal of Clinical Nutrition 57, Suppl. 256S-258S.
31. Diwadkar-Navsariwala V & Diamond AM (2004) The link between selenium and chemoprevention: a case for selenoporteins. Journal of Nutrition 134, 2899-2902.
32. Dong Y, Zhang H, Hawthorn L, Ganther HE & Ip C (2003) Delineation of the molecular basis for selenium-induced growth arrest in human prostate cancer cells by oligonucleotide array. Cancer Research 63, 52-59.
33. Duffield AJ, Thomson CD, Hill KE & Williams S (1999) An estimation of selenium requirements for New Zealanders. American Journal of Clinical Nutrition 70, 896-903.
34. Duffield-Lillico AJ, Dalkin BL, Reid ME, Turnbull BW, Slate EH, Jacobs ET, Marshall JR & Clark LC (2003a) Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial. British Journal of Urology 91, 608-612.
35. Duffield-Lillico AJ, Reid ME, Turnbull BW, Combs GF Jr, Slate EH, Fischbach LA, Marshall JR & Clark LC (2002) Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial. Cancer Epidemiology Biomarkers and Prevention 11, 630-639.
36. Duffield-Lillico AJ, Slate E, Reid ME, Turnbull BW, Wilkins PA, Combs Jr GF et al. (2003b) Selenium supplementation and secondary prevention of nonmelanoma skin cancer in a randomised trial. Journal of the National Cancer Institute 95, 1477-1481.
37. Fiala ES, Staretz ME, Pandya GA, El-Bayoumy K & Hamilton SR (1998) Inhibition of DNA cytosine methyltransferase by chemopreventive selenium compounds, determined by an improved assay for DNA cytosine methyltransferase and DNA cytosine methylation. Carcinogenesis 19, 597-604.
38. Frausto da Silva JJR & Williams RJP (2001) The Biological Chemistry of the Elements: The Inorganic Chemistry of Life, 2nd ed., p. 498. Oxford: Oxford University Press.
39. Ghosh J & Myers CE (1998) Inhibition of arachidonate 5-lipoxygenase triggers massive apoptosis in human prostate cancer cells. Proceedings of the National Academy of Sciences USA 95, 13182-13187.
40. Gladyshev VN, Factor VM, Housseau F & Hatfield DL (1998) Contrasting patterns of regulation of the antioxidant selenoproteins, thioredoxin reductase, and glutathione peroxidase, in cancer cells. Biochemical and Biophysical Research Communications 251, 488-493.
41. Goenaga Infante H, O'Connor G, Rayman M, Wahlen R, Entwisle J, Norris P, Hearn R & Catterick T (2004) Selenium speciation analysis of selenium-enriched supplements by HPLC with ultrasonic nebulisation ICP-MS and electrospray MS/MS detection. Journal of Analytical Atomic Spectrometry 19, 1529-1538.
42. Goenaga Infante H, O'Connor G, Rayman M, Wahlen R, Spalholz J, Norris P, Hearn R & Catterick T (2005) Identification of water-soluble γ-glutamyl-CH3SeCys in yeast-based Se supplements by HPLC with ICP-MS and electrospray tandem MS. Journal of Analytical Atomic Spectrometry 20, 864-870.
43. Goodman GE, Schaffer S, Bankson DD, Hughes MP, Omenn GS & the Carotene and Retinol Efficacy Trial (CARET) Co-Investigators (2001) Predictors of serum in cigarette smokers and the lack of association with lung and prostate cancer risk. Cancer Epidemiology Biomarkers and Prevention 10, 1069-1076.
44. Gopalakrishna R & Gundimeda U (2002) Antioxidant regulation of protein kinase C in cancer prevention. Journal of Nutrition 132, 3819S-3823S.
45. Greenberg ER, Baron JA, Tosteson TD, Freeman DH Jr, Beck GJ, Bond JH et al. (1994) A clinical trial of antioxidant vitamins to prevent colorectal adenoma. Polyp Prevention Study Group. New England Journal of Medicine 331, 141-147.
46. Hatfield DL & Gladyshev VN (2002) How selenium has altered our understanding of the genetic code. Molecular and Cell Biology 22, 3565-3576.
47. Helzlsouer KJ, Huang H-Y, Alberg AJ, Hoffman S, Burke A, Norkus EP, Morris JS & Comstock GW (2000) Association between alpha-tocopherol, gamma-tocopherol, selenium, and subsequent prostate cancer. Journal of the National Cancer Institute 92, 2018-2023.
48. Hsieh CL, Oakley-Girvan I, Balise RR, Halpern J, Gallagher RP, Wu AH et al. (2001) A Genome screen of families with multiple cases of prostate cancer: evidence of genetic heterogeneity. American Journal of Human Genetics 69, 148-158.
49. Hu YJ & Diamond AM (2003) Role of glutathione peroxidase 1 in breast cancer: loss of heterozygosity and allelic differences in the response to selenium. Cancer Research 63, 3347-3351.
50. Hu YJ, Dolan ME, Bae R, Yee H, Roy M, Glickman R, Kiremidjian-Schumacher L & Diamond AM (2004) Allelic loss at the GPx-1 locus in cancer of the head and neck. Biological Trace Element Research 101, 97-106.
51. Hu YJ, Korotkov KV, Mehta R, Hatfield DL, Rotimi CN, Luke A et al. (2001) Distribution and functional consequences of nucleotide polymorphisms in the 3′-untranslated region of the human Sep15 gene. Cancer Research 61, 2307-2310.
52. Ichimura Y, Habuchi T, Tsuchiya N, Wang L, Oyama C, Sato K, Nishiyama H, Ogawa O & Kato T (2004) Increased risk of bladder cancer associated with a glutathione peroxidase 1 codon 198 variant. Journal of Urology 172, 728-732.
53. Ip C (1998) Lessons from basic research in selenium and cancer prevention. Journal of Nutrition 128, 1845-1854.
54. Ip C, Birringer M, Block E, Kotrebai M, Tyson JF, Uden PC & Lisk DJ (2000) Chemical speciation influences comparative activity of selenium-enriched garlic and yeast in mammary cancer prevention. Journal of Agriculture and Food Chemistry 48, 2062-2070.
55. Ip C, Dong Y & Ganther HE (2002) New concepts in selenium chemoprevention. Cancer Metastasis Reviews 21, 281-289.
56. Ip C & Lisk DJ (1997) Modulation of phase I and phase II xenobiotic-metabolizing enzymes by selenium-enriched garlic in rats. Nutrition and Cancer 28, 184-188.
57. Jacobs ET, Jiang R, Alberts DS, Greenberg ER, Gunter EW, Karagas MR et al. (2004) Selenium and colorectal adenoma: results of a pooled analysis. Journal of the National Cancer Institute 96, 1669-1675.
58. Jiang C, Ganther H & Lu J (2000) Monomethyl selenium-specific inhibition of MMP-2 and VEGF expression: implications for angiogenic switch regulation. Molecular Carcinogenesis 29, 236-250.
59. Jiang C, Jiang W, Ip C, Ganther H & Lu J (1999) Selenium-induced inhibition of angiogenesis in mammary cancer at chemopreventive levels of intake. Molecular Carcinogenesis 26, 213-225.
60. Jiang C, Kim KH, Wang Z & Lu J (2004) Methyl selenium-induced vascular endothelial apoptosis is executed by caspases and principally mediated by p38 MAPK pathway. Nutrition and Cancer 49, 174-183.
61. Jiang C, Wang Z, Ganther H & Lu J (2001) Caspases as key executors of methyl selenium-induced apoptosis (anoikis) of DU-145 prostate cancer cells. Cancer Research 61, 3062-3070.
62. Kaeck M, Lu J, Strange R, Ip C, Ganther HE & Thompson HJ (1997) Differential induction of growth arrest inducible genes by selenium compounds. Biochemical Pharmacology 53, 921-926.
63. Karunasinghe N, Ryan J, Tuckey J, Masters J, Jamieson M, Clarke LC, Marshall JR & Ferguson LR (2004) DNA stability and serum selenium levels in a high-risk group for prostate cancer. Cancer Epidemiology Biomarkers and Prevention 13, 391-397.
64. Kim YS & Milner J (2001) Molecular targets for selenium in cancer prevention. Nutrition and Cancer 40, 50-54.
65. Kiremidjian-Schumacher L, Roy M, Glickman R, Schneider K, Rothstein S, Cooper J, Hochster H, Kim M & Newman R (2000) Selenium and immunocompetence in patients with head and neck cancer. Biological Trace Element Research 73, 97-111.
66. Kiremidjian-Schumacher L, Roy M, Wishe HI, Cohen MW & Stotzky G (1994) Supplementation with selenium and human immune cell functions. Biological Trace Element Research 41, 115-127.
67. Klein EA (2004) Selenium and vitamin E cancer prevention trial. Annals of the New York Academy of Sciences 1031, 234-241.
68. Knekt P (2002) Selenium status and prevention of chronic diseases. In Handbook of Antioxidants, pp. 665-687 [E Cadenas and L Packer editors]. New York and Basel: Marcel Dekker Inc.
69. Knekt P, Aromaa A, Maatela J, Alfthan G, Aaran RK, Hakama M, Hakulinen T, Peto R & Tepo L (1990) Serum selenium and subsequent risk of cancer among Finnish men and women. Journal of the National Cancer Institute 82, 864-868.
70. Knight JA, Onay UV, Wells S, Li H, Shi EJ, Andrulis IL & Ozcelik H (2004) Genetic variants of GPX1 and SOD2 and breast cancer risk at the Ontario site of the Breast Cancer Family Registry. Cancer Epidemiology Biomarkers and Prevention 13, 146-149.
71. Kok FJ, de Bruijn AM, Hofman A, Vermeeren R & Valkenburg HA (1987) Is serum selenium a risk factor for cancer in men only? American Journal of Epidemiology 125, 12-16.
72. Korotkov KV, Kumaraswamy E, Zhou Y, Hatfield DL & Gladyshev VN (2001) Association between the 15-kDa selenoprotein and UDP-glucose:glycoprotein glucosyltransferase in the endoplasmic reticulum of mammalian cells. Journal of Biological Chemistry 276, 15330-15336.
73. Kotrebai M, Birringer M, Tyson JF, Block E & Uden PC (2000) Selenium speciation in enriched and natural samples by HPLC-ICP-MS and HPLC-ESI-MS with perfluorinated carboxylic acid ion-pairing agents. Analyst 125, 71-78.
74. Kowalska E, Narod SA, Huzarski T, Zajaczek S, Huzarska J, Gorski B & Lubinski J (2005) Increased rates of chromosome breakage in BRCA1 carriers are normalized by oral selenium supplementation. Cancer Epidemiology Biomarkers and Prevention 14, 1302-1306.
75. Krishnaswamy K, Prasad MP, Krishna TP, Annapurna VV & Reddy GA (1995) A case study of nutrient intervention of oral precancerous lesions in India. European Journal of Cancer 31B, 41-48.
76. Kryukov GV, Castellano S, Novoselov SV, Lobanov AV, Zehtab O, Guigo R & Gladyshev VN (2003) Characterization of mammalian selenoproteomes. Science 300, 1439-1443.
77. Kumaraswamy E, Malykh A, Korotkov KV, Kozyavkin S, Hu Y, Kwon SY et al. (2000) Structure-expression relationships of the 15-kDa selenoprotein gene. Possible role of the protein in cancer etiology. Journal of Biological Chemistry 275, 35540-35547.
78. Lanfear J, Fleming J, Wu L, Webster G & Harrison PR (1994) The selenium metabolite selenodiglutathione induces p53 and apoptosis: relevance to the chemopreventive effects of selenium? Carcinogenesis 15, 1387-1392.
79. Li H, Kantoff PW, Giovannucci E, Leitzmann MF, Gaziano JM, Stampfer MJ & Ma J (2005) Manganese superoxide dismutase polymorphism, prediagnostic antioxidant status, and risk of clinical significant prostate cancer. Cancer Research 65, 2498-2504.
80. Li H, Stampfer MJ, Giovannucci EL, Morris JS, Willett WC, Gaziano JM & Ma J (2004) A prospective study of plasma selenium levels and prostate cancer risk. Journal of the National Cancer Institute 96, 696-703.
81. Li W, Zhu Y, Yan X, Zhang Q, Li X, Ni Z, Shen Z, Yao H & Zhu J (2000) The prevention of primary liver cancer by selenium in high risk populations. Zhonghua Yu Fang Yi Xue Za Zhi 34, 336-338.
82. Mark SD, Qiao YL, Dawsey SM, Wu YP, Katki H, Gunter EW, Fraumeni JF Jr, Blot WJ, Dong ZW & Taylor PR (2000) Prospective study of serum selenium levels and incident esophageal and gastric cancers. Journal of the National Cancer Institute 92, 1753-1763.
83. Marshall JR (2001) Larry Clark's legacy: randomized controlled, selenium-based prostate cancer chemoprevention trials. Nutrition and Cancer 40, 74-77.
84. Medina D & Morrison D (1988) Current ideas on selenium as a chemopreventive agent. Pathology and Immunopathology Research 7, 187-199.
85. Medina D, Thompson H, Ganther H & Ip C (2001) Se- methylselenocysteine: a new compound for chemoprevention of breast cancer. Nutrition and Cancer 40, 12-17.
86. Nakamuro K, Nakanishi K, Okuno T, Hasegawa T & Sayato Y (1997) Comparison of methylated selenium metabolites in rats after oral administration of various selenium compounds. Japanese Journal of Toxicology and Environmental Health 43, 1482-1489.
87. Nomura AM, Lee J, Stemmermann GN & Combs GF Jr (2000) Serum selenium and subsequent risk of prostate cancer. Cancer Epidemiology Biomarkers and Prevention 9, 883-887.
88. Okuno T, Motobayashi S, Ueno H & Nakamuro K (2005) Purification and characterization of mouse hepatic enzyme that converts selenomethionine to methylselenol by its alpha, gamma-elimination. Biological Trace Element Research 106, 77-94.
89. Overvad K (1998) Selenium and Cancer. In Role of Trace Elements for Health Promotion and Disease Prevention, pp. 141-149 [B Sandstrom and P Walter, editors]. Basel: Karger.
90. Platz EA & Helzlsouer KJ (2001) Selenium, zinc, and prostate cancer. Epidemiol Rev 23, 93-101.
91. Prasad MP, Mukundan MA & Krishnaswamy K (1995) Micronuclei and carcinogen DNA adducts as intermediate end points in nutrient intervention trial of precancerous lesions in the oral cavity. European Journal of Cancer 31B, 155-159.
92. Ratnasinghe D, Tangrea JA & Andersen JA (2000) Glutathione peroxidase codon 198 polymorphism variant increases lung cancer risk. Cancer Research 60, 6381-6383.
93. Rayman MP (2000) The importance of selenium to human health. Lancet 356, 233-241.
94. Rayman MP (2002) The argument for increasing selenium intake. Proceedings of the Nutrition Society 61, 203-215.
95. Rayman MP (2004) The use of high-selenium yeast to raise selenium status: how does it measure up? British Journal of Nutrition 92, 557-573.
96. Salonen JT, Salonen R, Lappetelainen R, Maenpaa P, Alfthan G & Puska P (1985) Risk of cancer in relation to serum concentrations of selenium and vitamins A and E: matched case-control analysis of prospective data. British Medical Journal 290, 417-120.
97. Schatzkin A, Lanza E, Corle D, Lance P, Iber F, Caan B et al. (2000) Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. Polyp Prevention Trial Study Group. New England Journal of Medicine 342, 1149-1155.
98. Schrauzer GN, White DA & Schneider CJ (1977) Cancer mortality correlation studies. III. Statistical association with dietary selenium intakes. Bioinorganic Chemistry 7, 23-31.
99. Shamberger RJ & Frost DV (1969) Possible protective effect of selenium against human cancer. Canadian Medical Association Journal 100, 682.
100. Smith ML, Lancia JK, Mercer TI & Ip C (2004) Selenium compounds regulate p53 by common and distinctive mechanisms. Anticancer Research 24, 1401-1408.
101. Spallholz JE, Boylan LM & Larsen HS (1990) Advances in understanding selenium's role in the immune system. Annals of the New York Academy of Sciences 587, 123-139.
102. Spallholz JE, Palace VP & Reid TW (2004) Methioninase and selenomethionine but not Se-methylselenocysteine generate methylselenol and superoxide in an in vitro chemiluminescent assay: implications for the nutritional carcinostatic activity of selenoamino acids. Biochemical Pharmacology 67, 547-554.
103. Stratton MS, Reid ME, Schwartzberg G, Minter FE, Monroe BK, Alberts DS, Marshall JR & Ahmann FR. (2003a) Selenium and prevention of prostate cancer in high-risk men: the Negative Biopsy Study. Anticancer Drugs 14, 589-594.
104. Stratton MS, Reid ME, Schwartzberg G, Minier FE, Monroe BK, Alberts DS, Marshall JR & Ahmann FR (2003b) Selenium and inhibition of disease progression in men diagnosed with proslale carcinoma: study design and baseline characteristics of lhe 'Watchful Waiting' Study. Anticancer Drugs 14, 595-600.
105. Sunde RA (1997) Selenium. In Handbook of Nutritionally Essential Mineral Elements, pp. 493-556 [BL O'Dell and RA Sunde, editors]. New York: Marcel Dekker, Inc.
106. Thomson CD, Robinson MF, Butler JA & Whanger PD (1993) Long-term supplementation with selenate and selenomethionine: selenium and glutathione peroxidase (EC 1-11.1.9) in blood components of New Zealand women. British Journal of Nutrition 69, 577-588.
107. Unni E, Singh U, Ganther HE & Sinha R (2001) Se-methylselenocysteine activates caspase-3 in mouse mammary epithelial tumor cells in vitro. Biofactors 14, 169-177.
108. van den Brandt PA, Zeegers MP, Bode P & Goldbohm RA (2003) Toenail selenium levels and the subsequent risk of prostate cancer: a prospective cohort study. Cancer Epidemiology Biomarkers and Prevention 12, 866-871.
109. Villette S, Kyle JA, Brown KM, Pickard K, Milne JS, Nicol F, Arthur JR & Hesketh JE (2002) A novel single nucleotide polymorphism in the 3′ untranslated region of human glutathione peroxidase 4 influences lipoxygenase metabolism. Blood Cells, Molecules and Diseases 29, 174-178.
110. Wang Z, Jiang C & Lu J (2002) Induction of caspase-mediated apoptosis and cell-cycle G1 arrest by selenium metabolite methylselenol. Molecular Carcinogenesis 34, 113-120.
111. Waters DJ, Shen S, Cooley DM, Bostwick DG, Qian J, Combs GF Jr, Glickman LT, Oteham C, Schlittler D & Morris JS (2003) Effects of dietary selenium supplementation on DNA damage and apoptosis in canine prostate. Journal of the National Cancer Institute 95, 237-244.
112. Waters DJ, Shen S, Glickman LT, Cooley DM, Bostwick DG, Qian J, Combs GF Jr & Morris JS (2005) Prostate cancer risk and DNA damage: translational significance of selenium supplementation in a canine model. Carcinogenesis 26, 1256-1262.
113. Wei WQ, Abnet CC, Qiao YL, Dawsey SM, Dong ZW, Sun XD, Fan JH, Gunter EW, Taylor PR & Mark SD (2004) Prospective study of serum selenium concentrations and esophageal and gastric cardia cancer, heart disease, stroke, and total death. American Journal of Clinical Nutrition 79, 80-85.
114. Weingarten M, Zalmanovici A & Yaphe J (2005) Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps. The Cochrane Database of Systematic Reviews 2005, issue 2. Bognor Regis, West Sussex: John Wiley & Sons Ltd.
115. Whanger PD (2004) Selenium and its relationship to cancer: an update. British Journal of Nutrition 91, 11-28.
116. Wiklund F, Gillanders EM, Albertus JA, Bergh A, Damber JE, Emanuelsson M et al. (2003) Genome-wide scan of Swedish families with hereditary prostate cancer: Suggestive evidence of linkage at 5q11.2 and 19p13.3. The Prostate 57, 290-297.
117. Willett WC, Polk BF, Morris JS, Stampfer MJ, Pressel S, Rosner B, Taylor JO, Schneider K & Harnes CG (1983) Prediagnostic serum selenium and risk of cancer. Lancet 16, 130-134.
118. Xia Y, Hill KE, Byrne DW, Xu J & Burk RF (2005) Effectiveness of selenium supplements in a low-selenium area of China. American Journal of Clinical Nutrition 81, 829-834.
119. Yoon SO, Kim MM & Chung AS (2001) Inhibitory effect of selenite on invasion of HT1080 tumor cells. Journal of Biological Chemistry 276, 20085-20092.
120. Yoshizawa K, Willett WC, Morris SJ, Stampfer MJ, Spiegelman D, Rimm EB & Giovanucci E (1998) Study of prediagnostic selenium levels in toenails and the risk of advanced prostate cancer. Journal of the National Cancer Institute 90, 1219-1224.
121. Yu MW, Horng IS, Hsu KH, Chiang YC, Liaw YF & Chen CJ (1999) Plasma selenium levels and the risk of hepatocellular carcinoma among men with chronic hepatitis virus infection. American Journal of Epidemiology 150, 367-374.
122. Yu SY, Zhu YJ & Li WG (1997) Protective role of selenium against hepatitis B virus and primary liver cancer in Qidong. Biological Trace Element Research 56, 117-124.
123. Zhuo H, Smith AH & Steinmaus C (2004) Selenium and lung cancer: a quantitative analysis of heterogeneity in the current epidemiological literature. Cancer Epidemiology Biomarkers and Prevention 13, 771-778.
124. Zu K & Ip C (2003) Synergy between selenium and vitamin E in apoptosis induction is associated with activation of distinctive initiator caspases in human prostate cancer cells. Cancer Research 63, 6988-6995.